Trans-plasma membrane electron transport (t-PMET) has been established since the 1960s, but it has only been subject to more intensive research in the last decade. The discovery and characterization at the molecular level of its novel components has increased our understanding of how t-PMET regulates distinct cellular functions. This review will give an update on t-PMET, with particular emphasis on how its malfunction relates to some diseases, such as cancer, abnormal cell death, cardiovascular diseases, aging, obesity, neurodegenerative diseases, pulmonary fibrosis, asthma, and genetically linked pathologies. Understanding these relationships may provide novel therapeutic approaches for pathologies associated with unbalanced redox state. Antioxid. Redox Signal. 14, 2289–2318.
Abdala-ValenciaH, EarwoodJ, BansalS, JansenM, BabcockG, GarvyB, Wills-KarpM, Cook-MillsJM. Nonhematopoietic NADPH oxidase regulation of lung eosinophilia and airway hyperresponsiveness in experimentally induced asthma. Am J Physiol Lung Cell Mol Physiol, 292:L1111–L1125. 2007.
2.
AboA, BoyhanA, WestI, ThrasherAJ, SegalAW. Reconstitution of neutrophil NADPH oxidase activity in the cell-free system by four components: p67-phox, p47-phox, p21 racl and cytochrome b-245. J Biol Chem, 267:16767–16770. 1992.
3.
AdamsV, LinkeA, KrankelN, ErbsS, GielenS, Mobius-WinklerS, GummertJF, MohrFW, SchulerG, HambrechtR. Impact of regular physical activity on the NAD(P)H oxidase and angiotensin receptor system in patients with coronary artery disease. Circulation, 111:555–562. 2005.
4.
AdrainC, MartinSJ. The mitochondrial apoptosome: a killer unleashed by the cytochrome seas. Trends Biochem Sci, 26:390–397. 2001.
5.
AgoT, KitazonoT, OoboshiH, IyamaT, HanYH, TakadaJ, WakisakaM, IbayashiS, UtsumiH, IidaM. Nox4 as the major catalytic component of an endothelial NAD(P)H oxidase. Circulation, 109:227–233. 2004.
6.
AitkenRJ, BakerMA. Oxidative stress and male reproductive biology. Reprod Fert Dev, 16:581–588. 2004.
7.
AkandaN, TofighiR, BraskJ, TammC, ElinderF, CeccatelliS. Voltage-dependent anion channels (VDAC) in the plasma membrane play a critical role in apoptosis in differentiated hippocampal neurons but not in neural stem cells. Cell Cycle, 7:3225–3234. 2008.
8.
AmerJ, FibachE. Oxidative status of platelets in normal and thalassemic blood. Thromb Haemost, 92:1052–1059. 2004.
9.
AmerJ, GhotiH, RachmilewitzE, KorenA, LevinC, FibachE. Red blood cells, platelets and polymorphonuclear neutrophils of patients with sickle cell disease exhibit oxidative stress that can be ameliorated by antioxidants. Br J Haematol, 132:108–113. 2006.
ArrigoniO, DipierroS, BorraccinoG. Ascorbate free radical reductase, a key enzyme of the ascorbic acid system. FEBS Lett, 125:242–244. 1981.
12.
ArroyoA, KaganVE, TyurinVA, BurgessJR, de CaboR, NavasP, VillalbaJM. NADH and NADPH-dependent reduction of coenzyme Q at the plasma membrane. Antioxid Redox Signal, 2:251–262. 2000.
13.
AsherG, BercovichZ, TsvetkovP, ShaulY, KahanaC. 20S proteasomal degradation of onithine decarboxylase is regulated by NQO1. Mol Cell, 17:645–655. 2005.
14.
AsherG, TsvetkovP, KahanaC, ShaulY. A mechanism of ubiquitin-independent proteasomal degradation of the tumour suppressor p53 and p73. Genes Dev, 19:316–321. 2005.
15.
AviglianoL, SaviniI, CataniMV, Del PrincipeD. Trans-plasma membrane electron transport in human blood platelets. Mini Rev Med Chem, 8:555–563. 2008.
16.
BainesCP, KaiserRA, SheikoT, CraigenWJ, MolkentinJD. Voltage-dependent anion channels are dispensable for mitochondrial-dependent cell death. Nat Cell Biol, 9:550–555. 2007.
17.
BakerMA, AitkenRJ. The importance of redox regulated pathways in sperm cell biology. Mol Cell Endocrinol, 216:47–54. 2004.
18.
BakerMA, KrutskikhA, CurryBJ, HetheringtonL, AitkenRJ. Identification of cytochrome b5-reductase as the enzyme responsible for NADH-dependent lucigenin chemiluminescence in human spermatozoa. Biol Reprod, 73:334–342. 2005.
19.
BakerMA, KrutskikhA, CurryBJ, McLaughlinEA, AitkenRJ. Identification of cytochrome p450-reductase as the enzyme responsible for NADPH-dependent lucigenin and tetrazolium salt reduction in rat epididymal sperm preparations. Biol Reprod, 71:307–318. 2004.
20.
BakerMA, LaneDJ, LyJD, De PintoV, LawenA. VDAC1 is a transplasma membrane NADH-ferricyanide reductase. J Biol Chem, 279:4811–4819. 2004.
21.
BakerMA, ReevesG, HetheringtonL, MüllerJ, BaurI, AitkenRJ. Identification of gene products present in Triton X-100 soluble and insoluble fractions of human spermatozoa lysates using LC-MS/MS analysis. Proteomics Clin Appl, 1:524–532. 2007.
22.
BalusikovaK, NeubauerovaJ, Dostalikova-CimburovaM, HorakJ, KovarJ. Differing expression of genes involved in non-transferrin iron transport across plasma membrane in various cell types under iron deficiency and excess. Mol Cel Biochem, 321:123–133. 2009.
23.
BanfiB, MolnarG, MaturanaA, StegerK, HegedusB, DemaurexN, KrauseKH. A Ca(2+)-activated NADPH oxidase in testis, spleen, and lymph nodes. J Biol Chem, 276:37594–37601. 2001.
24.
BánfiB, TironeF, DurusselI, KniszJ, MoskwaP, MolnárGZ, KrauseKH, CoxJA. Mechanism of Ca2+ activation of the NADPH oxidase 5 (NOX5)J Biol Chem, 279:18583–18591. 2004.
25.
BaoutinaA, DeanRT, JessupW. Trans-plasma membrane electron transport induces macrophage-mediated low density lipoprotein oxidation. FASEB J, 15:1580–1582. 2001.
26.
BayrhuberM, MeinsT, HabeckM, BeckerS, GillerK, VillingerS, VonrheinC, GriesingerC, ZweckstetterM, ZethK. Structure of the human voltage-dependent anion channel. Proc Natl Acad Sci U S A, 105:15370–15375. 2008.
27.
BenzR. Permeation of hydrophilic solutes through mitochondrial outer membranes: Review on mitochondrial porins. Biochim Biophys Acta, 1197:167–196. 1994.
28.
BerridgeMV, TanAS. Cell surface NAD(P)H-oxidase: relationship to transplasma membrane NADH-oxidoreductase and a potential source of circulating NADH-oxidase. Antioxid Redox Signal, 2:277–288. 2000.
29.
BerridgeMV, TanAS. High-capacity redox control at the plasma membrane of mammalian cells: trans-membrane, cell surface, and serum NADH-oxidases. Antioxid Redox Signal, 2:231–242. 2000.
30.
BerridgeMV, TanAS. Trans-plasma membrane electron transport: a cellular assay for NADH- and NADPH-oxidase based on extracellular, superoxide-mediated reduction of the sulfonated tetrazolium salt WST-1. Protoplasma, 205:74–82. 1998.
31.
BerridgeMV, HerstPM, LawenA. Targeting mitochondrial permeability in cancer drug development. Mol Nutr Food Res, 53:76–86. 2009.
32.
BerridgeMV, HerstPM, TanAS. Tetrazolium dyes as tools in cell biology: new insights into their cellular reduction. Biotechnol Annu Rev, 11:127–152. 2005.
33.
BewleyMC, MarohnicCC, BarberMJ. The structure and biochemistry of NADH-dependent cytochrome b5 reductase are now consistent. Biochemistry, 40:13574–13582. 2001.
34.
BianchetMA, FaigM, AmzelLM. Structure and mechanism of NAD[P]H:quinone acceptor oxidoreductases (NQO)Methods Enzymol, 382:144–174. 2004.
35.
BjörnstedtM, NordmanT, OlssonJM. Extramitochondrial reduction of ubiquinone by flavoenzymes. Methods Enzymol, 378:131–138. 2004.
36.
BlockML. NADPH oxidase as a therapeutic target in Alzheimer's disease. BMC Neurosci, 9:S8–S15. 2008.
37.
BokochGM, DieboldB, KimJS, GianniD. Emerging evidence for the importance of phosphorylation in the regulation of NADPH oxidases. Antioxid Redox Signal, 11:2429–2441. 2009.
BuettnerR, PapoutsoglouG, ScemesE, SprayDC, DermietzelR. Evidence for secretory pathway localization of a voltage-dependent anion channel isoform. Proc Natl Acad Sci U S A, 97:3201–3206. 2000.
45.
CampanellaME, ChuH, LowPS. Assembly and regulation of a glycolytic enzyme complex on the human erythrocyte membrane. Proc Natl Acad Sci U S A, 102:2402–2407. 2005.
46.
ChamulitratW, SchmidtR, TomakidiP, StremmelW, ChunglokW, KawaharaT, RokutanK. Association of gp91phox homolog Nox1 with anchorage-independent growth and MAP kinase-activation of transformed human keratinocytes. Oncogene, 22:6045–6053. 2003.
47.
ChenCF, HuangS, LiuSC, ChuehPJ. Effect of polyclonal antisera to recombinant tNOX protein on the growth of transformed cells. Biofactors, 28:119–133. 2006.
48.
ChengG, LambethJD. NOXO1, regulation of lipid binding, localization, and activation of Nox1 by the Phox homology (PX) domain. J Biol Chem, 279:4737–4742. 2004.
49.
ChengG, CaoZ, XuX, van MeirEG, LambethJD. Homologs of gp91phox: cloning and tissue expression of Nox3, Nox4, and Nox5. Gene, 269:131–140. 2001.
50.
ChengG, DieboldBA, HughesY, LambethJD. Nox1-dependent reactive oxygen generation is regulated by Rac1. J Biol Chem, 281:17718–17726. 2006.
51.
ChoNM, ChuehP-J, KimC, CaldwellS, MorréDM, MorréDJ. Monoclonal antibody to a cancerspecific and drug-responsive hydroquinone (NADH) oxidase from the sera of cancer patients. Cancer Immunol Immunother, 51:121–129. 2002.
52.
ChuehP-J, KimC, ChoN, MorréDM, MorréDJ. Molecular cloning and characterization of a tumor-associated, growth-related and time-keeping hydroquinone (NADH) oxidase (NOX) of the HeLa cell surface. Biochemistry, 41:3732–3741. 2002.
53.
ChuehP-J, MorréDM, MorréDJ. A site directed mutagenesis analysis of tNOX functional domains. Biochim Biophys Acta, 1594:74–83. 2002.
54.
ChuehPJ, WuLY, MorréDM, MorréDJ. tNOX is both necessary and sufficient as a cellular target for the anticancer actions of capsaicin and the green tea catechin (-)-epigallocatechin-3-gallate. Biofactors, 20:235–249. 2004.
55.
CimenMY. Free radical metabolism in human erythrocytes. Clin Chim Acta, 390:1–11. 2008.
56.
ClarkRA, VolppBD, LeidalKG, NauseefWM. Translocation of cytosolic components of neutrophil NADPH oxidase. Trans Assoc Am Physicians, 102:224–230. 1989.
57.
ColombiniM. Structure and mode of action of a voltage dependent anion-selective channel (VDAC) located in the outer mitochondrial membrane. Ann N Y Acad Sci, 341:552–563. 1980.
58.
CorrellCC, BatieCJ, BallouDP, LudwigML. Phthalate dioxygenase reductase: a modular structure for electron transfer from pyridine nucleotides to [2Fe-2S]Science, 258:1604–1610. 1992.
59.
CraneFL, LöwH. NADH oxidation in liver and fat cell plasma membranes. FEBS Lett, 68:153–156. 1976.
60.
CraneFL, LöwH. Reactive oxygen species generation at the plasma membrane for antibody control. Autoimmun Rev, 7:518–522. 2008.
61.
CraneFL, SunIL, ClarkMG, GrebingC, LöwH. Transplasma-membrane redox systems in growth and development. Biochim Biophys Acta, 811:233–264. 1985.
62.
CraneFL, SunIL, CroweR, LöwH. Electron and proton transport across the plasma membrane. J Bioenerg Biomemb, 23:773–803. 1991.
63.
CraneFL, SunIL, CroweRA, LöwH. Oxidase control of plasma membrane proton transport. Principles of Medical Biology: 4, Cell Chemistry and Physiology, Part III. BittarEE, BittarN. Greenwich, CT: JAI Press, 1996; 169–186.
64.
CraneFL. Biochemical functions of coenzyme Q10. J Am Coll Nutr, 20:591–598. 2001.
65.
CraneFL. The evolution of coenzyme Q. BioFactors, 32:5–11. 2008.
66.
CuiW, MatsunoK, IwataK, IbiM, KatsuyamaM, KakehiT, SasakiM, IkamiK, ZhuK, Yabe-NishimuraC. NADPH oxidase isoforms and anti-hypertensive effects of atorvastatin demonstrated in two animal models. J Pharmacol Sci, 111:260–268. 2009.
67.
CullenJJ, HinkhouseMM, GradyM, GautAW, LiuJ, ZhangYP, Darby WeydertCJ, DomannFE, OberleyLW. Dicoumarol inhibition of NAD(P)H quinone oxidoreductase induces growth inhibition of pancreatic cancer via a superoxide mediated mechanism. Cancer Res, 63:5513–5520. 2003.
68.
DaltonDA, LangebergL, RobbinsM. Purification and characterization of monodehydroascorbate reductase from soybean root nodules. Arch Biochem Biophys, 292:281–286. 1992.
69.
De CaboR, CabelloR, RiosM, Lopez-LluchG, IngramDK, LaneMA, NavasP. Calorie restriction attenuates age-related alterations in the plasma membrane antioxidant system in rat liver. Exp Gerontol, 39:297–304. 2004.
70.
De DekenX, WangD, ManyMC, CostagliolaS, LibertF, VassartG, DumontJE, MiotF. Cloning of two human thyroid cDNAs encoding new members of the NADPH oxidase family. J Biol Chem, 275:23227–23233. 2000.
71.
De LaurenziV, MelinoG, SaviniI, Annichiarico-PetruzzelliM, Finazzi-AgròA, AviglianoL. Cell death by oxidative stress and ascorbic acid regeneration in human neuroectodermal cell lines. Eur J Cancer, 31:463–466. 1995.
72.
De LucaT, BosneagaE, MorréDM, MorréDJ. Downstream targets of altered sphingolipid metabolism in response to inhibition of ENOX2 by phenoxodiol. Biofactors, 34:253–260. 2009.
73.
De LucaT, MorréDM, ZhaoH, MorréDJ. NAD+/NADH and/or CoQ/CoQH2 ratios from plasma membrane electron transport may determine ceramide and sphingosine-1-phosphate levels accompanying G1 arrest and apoptosis. Biofactors, 25:43–60. 2005.
74.
De PintoV, MessinaA, LaneDJ, LawenA. Voltage-dependent anion-selective channel (VDAC) in the plasma membrane. FEBS Lett, 584:1793–1799. 2010.
75.
DedovVN, MandadiS, ArmatiPJ, VerkhratskiA. Capsaicin-induced depolarization of mitochondria in dorsal root ganglion neurons is enhanced by vanilloid receptors. Neuroscience, 103:219–226. 2001.
76.
Del PrincipeD, FregaG, SaviniI, CataniMV, RossiA, AviglianoL. The plasma membrane redox system in human platelet functions and platelet-leukocyte interactions. Thromb Haemost, 101:284–289. 2009.
77.
Del PrincipeD, MancusoG, MenichelliA, GabriottiM, CosmiEV, GherardiG. Production of hydrogen peroxide in phagocyting human platelets: an electron microscopic cytochemical demonstration. Biol Cell, 38:135–140. 1980.
78.
del ValleAE, del Castillo-OlivaresA, Sanchez-JimenezF, MarquezJ, Nunez de CastroI, MedinaMA. Plasma membrane redox system activity in tumour cell lines of mammary origins with different proliferation rates. Protoplasma, 205:169–173. 1998.
79.
DinauerMC, OrkinSH, BrownR, JesaitisAJ, ParkosCA. The glycoprotein encoded by the X-linked chronic granulomatous disease locus is a component of the neutrophil cytochrome b complex. Nature, 327:717–720. 1987.
80.
DinauerMC, PierceEA, BrunsGAP, CumutteJT, OrkinSH. Human neutrophil cytocrome-b light chain (p22-phox): Gene structure, chromosomal location, and mutations in cytochrome negative autosomal recessive chronic granulomatous disease. J Clin Invest, 86:1729–1737. 1990.
81.
DringenR, PfeifferB, HamprechtB. Synthesis of the antioxidant glutathione in neurons: supply by astrocytes of CysGly as precursor for neuronal glutathione. J Neurosci, 19:562–569. 1999.
82.
DuM, ShirabeK, TakeshitaM. Identification of alternative first exons of NADH-cytochrome b5 reductase gene expressed ubiquitously in human cells. Biochem Biophys Res Commun, 235:779–783. 1997.
83.
DusiS, DoniniM, LissandriniD, MazziP, BiancaVD, RossiF. Mechanisms of expression of NADPH oxidase components in human cultured monocytes: role of cytokines and transcriptional regulators involved. Eur J Immunol, 31:929–938. 2001.
84.
ElinderF, AkandaN, TofighiR, ShimizuS, TsujimotoY, OrreniusS, CeccatelliS. Opening of plasma membrane voltage-dependent anion channels (VDAC) precedes caspase activation in neuronal apoptosis induced by toxic stimuli. Cell Death Differ, 12:1134–1140. 2005.
85.
Fernández-AyalaDJ, Brea-CalvoG, López-LluchG, NavasP. Coenzyme Q distribution in HL-60 human cells depends on the endomembrane system. Biochim Biophys Acta, 1713:129–137. 2005.
86.
FioraniM, AccorsiA. Dietary flavonoids as intracellular substrates for an erythrocyte trans-plasma membrane oxidoreductase activity. Br J Nutr, 94:338–345. 2005.
87.
FischerH. Mechanisms and function of DUOX in epithelia of the lung. Antioxid Redox Signal, 11:2453–2465. 2009.
FlemingPJ, KentUM. Cytochrome b561, ascorbic acid, and transmembrane electron transfer. Am J Clin Nutr, 54:1173S–1178S. 1991.
90.
FortuñoA, OlivánS, BeloquiO, San JoseG, MorenoMU, DiezJ, ZalbaG. Association of increased phagocytic NADPH oxidase-dependent superoxide production with diminished nitric oxide generation in essential hypertension. J Hypertens, 22:2169–2175. 2004.
91.
FortuñoA, San JoséG, MorenoMU, BeloquiO, DíezJ, ZalbaG. Phagocytic NADPH oxidase overactivity underlies oxidative stress in metabolic syndrome. Diabetes, 55:209–215. 2006.
FukuiT, IshizakaN, RajagopalanS, LaursenJB, CapersQ4th, TaylorWR, HarrisonDG, de LeonH, WilcoxJN, GriendlingKK. p22phox mRNA expression and NADPH oxidase activity are increased in aortas from hypertensive rats. Circ Res, 80:45–51. 1997.
94.
FurukawaS, FujitaT, ShimabukuroM, IwakiM, YamadaY, NakajimaY, NakayamaO, MakishimaM, MatsudaM, ShimomuraI. Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest, 114:1752–1761. 2004.
95.
GaikwadA, Long IIDJ, StringerJL, JaiswalAK. In vivo role of NAD(P)H: quinone oxidoreductase 1 (NQO1) in the regulation of intracellular redox state and accumulation of abdominal adipose tissue. J Biol Chem, 276:22559–22564. 2001.
96.
GeisztM, LetoTL. The Nox family of NAD(P)H oxidases: host defense and beyond. J Biol Chem, 279:51715–51718. 2004.
97.
GeisztM, LekstromK, WittaJ, LetoTL. Proteins homologous to p47phox and p67phox support superoxide production by NAD(P)H oxidase 1 in colon epithelial cells. J Biol Chem, 278:20006–20012. 2003.
98.
GhioAJ, Nozik-GrayckE, TuriJ, JaspersI, MercatanteDR, KoleR, PiantadosiCA. Superoxide-dependent iron uptake: a new role for anion exchange protein 2. Am J Respir Cell Mol Biol, 29:653–660. 2003.
99.
Gomez-DiazC, Rodrıguez-AguileraJC, BarrosoMP, VillalbaJM, NavarroF, CraneFL, NavasP. Antioxidant ascorbate is stabilized by NADH-coenzyme Q10 reductase in the plasma membrane. J Bioenerg Biomembr, 29:251–257. 1997.
100.
Gómez-DíazC, VillalbaJM, Pérez-VicenteR, CraneFL, NavasP. Ascorbate stabilization is stimulated in ρo HL-60 cells by CoQ10 increase at the plasma membrane. Biochem Biophys Res Commun, 234:79–81. 1997.
101.
Gonzalez-GronowM, KalfaT, JohnsonCE, GawdiG, PizzoSV. The voltage-dependent anion channel is a receptor for plasminogen kringle 5 on human endothelial cells. J Biol Chem, 278:27312–27318. 2003.
102.
GrebingC, CraneFL, LöwH, HallK. A transmembranous NADH-dehydrogenase in human erythrocyte membranes. J Bioenerg Biomembr, 16:517–533. 1984.
103.
GriendlingKK, SorescuD, Ushio-FukaiM. NAD(P)H oxidase: role in cardiovascular biology and disease. Circ Res, 86:494–501. 2000.
104.
GriffithsHR. Is the generation of neo-antigenic determinants by free radicals central to the development of autoimmune rheumatoid disease?Autoimmun Rev, 7:544–549. 2008.
105.
GuichardC, MoreauR, PessayreD, EppersonTK, KrauseKH. NOX family NADPH oxidases in liver and in pancreatic islets: a role in the metabolic syndrome and diabetes?Biochem Soc Trans, 36:920–929. 2008.
106.
GunshinH, StarrCN, DirenzoC, FlemingMD, JinJ, GreerEL, SellersVM, GalicaSM, AndrewsNC. Cybrd1 (duodenal cytochrome b) is not necessary for dietary iron absorption in mice. Blood, 106:2879–2883. 2005.
107.
HaraT, MinakamiS. On functional role of cytochrome b5. J Biochem, 69:325–330. 1971.
HerstPM, BerridgeMV. Cell surface oxygen consumption: a major contributor to cellular oxygen consumption in glycolytic cancer cell lines. Biochim Biophys Acta, 1767:170–177. 2007.
110.
HerstPM, BerridgeMV. Plasma membrane electron transport: a new target for cancer drug development. Curr Mol Med, 6:895–904. 2006.
111.
HerstPM, PetersenT, JerramP, BatyJ, BerridgeMV. The antiproliferative effects of phenoxodiol are associated with inhibition of plasma membrane electron transport in tumour cell lines and primary immune cells. Biochem Pharmacol, 74:1587–1595. 2007.
HicksC, MorréDJ. Oxidation of NADH by intact segments of soybean hypocotyls and stimulation by 2,4-D. Biochim Biophys Acta, 1375:1–5. 1998.
114.
HimmelreichU, DrewKN, SerianniAS, KuchelPW. 13C NMR studies of vitamin C transport and its redox cycling in human erythrocytes. Biochemistry, 37:7578–7588. 1998.
115.
HimmelreichU, KuchelPW. 13C-NMR studies of transmembrane electron transfer to extracellular ferricyanide in human erythrocytes. Eur J Biochem, 246:638–645. 1997.
HollaIL, KankováK, ZnojilV. Haplotype analysis of the NADPH oxidase p22 phox gene in patients with bronchial asthma. Int Arch Allergy Immunol, 148:73–80. 2009.
118.
HosodaS, NakamuraW, HayashiK. Properties and reaction mechanism of DT diaphorase from rat liver. J Biol Chem, 249:6416–6423. 1974.
119.
HostetlerB, WestonN, KimC, MorréDM, MorréDJ. Cancer site-specific isoforms of ENOX2 (tNOX), a cancer-specific cell surface oxidase. Clin Proteom, 5:46–51. 2009.
HoutkooperRH, CantóC, WandersRJ, AuwerxJ. The secret life of NAD+: an old metabolite controlling new metabolic signaling pathways. Endocr Rev, 31:194–223. 2010.
122.
HsiehTC, LuX, WangZ, WuJM. Induction of quinone reductase NQO1 by resveratrol in human K562 cells involves the antioxidant response element ARE and is accompanied by nuclear translocation of transcription factor Nrf2. Med Chem, 2:275–285. 2006.
HuangJ, CanadienV, LamGY, SteinbergBE, DinauerMC, MagalhaesMA, GlogauerM, GrinsteinS, BrumellJH. Activation of antibacterial autophagy by NADPH oxidases. Proc Natl Acad Sci U S A, 106:6226–6631. 2009.
125.
HultquistDE, PassonPG. Catalysis of methaemoglobin reduction by erythrocyte cytochrome B5 and cytochrome B5 reductase. Nat New Biol, 229:252–254. 1971.
126.
HwangJH, KimDW, JoEJ, KimYK, JoYS, ParkJH, YooSK, ParkMK, KwakTH, KhoYL, HanJ, ChoiHS, LeeSH, KimJM, LeeI, KyungT, JangC, ChungJ, KweonGR, ShongM. Pharmacological stimulation of NADH oxidation ameliorates obesity and related phenotypes in mice. Diabetes, 58:965–974. 2009.
127.
HyunDH, EmersonSS, JoDG, MattsonMP, de CaboR. Calorie restriction up-regulates the plasma membrane redox system in brain cells and suppresses oxidative stress during aging. Proc Natl Acad Sci U S A, 103:19908–19912. 2006.
128.
HyunDH, HernandezJO, MattsonMP, de CaboR. The plasma membrane redox system in aging. Ageing Res Rev, 5:209–220. 2006.
JagnandanD, ChurchJE, BanfiB, StuehrDJ, MarreroMB, FultonDJ. Novel mechanism of activation of NADPH oxidase 5. Calcium sensitization via phosphorylation. J Biol Chem, 282:6494–6507. 2007.
131.
JaiswalAK. Human NAD(P)H:quinone oxidoreductase (NQO1) gene structure and induction by dioxin. Biochemistry, 30:10647–10653. 1991.
132.
JanaA, PahanK. Fibrillar amyloid-beta peptides kill human primary neurons via NADPH oxidase-mediated activation of neutral sphingomyelinase. Implications for Alzheimer's disease. J Biol Chem, 279:51451–51459. 2004.
133.
JiangZ, GorensteinNM, MorréDM, MorréDJ. Molecular cloning and characterization of a candidate human growth-related and time-keeping constitutive cell surface hydroquinone (NADH) oxidase. Biochemistry, 47:14028–14038. 2008.
134.
JonesW, LiX, QuZC, PerriottL, WhitesellRR, MayJM. Uptake, recycling, and antioxidant actions of α-lipoic acid in endothelial cells. Free Radic Biol Med, 33:83–93. 2002.
135.
JungJ, HwangSW, KwakJ, LeeSY, KangCJ, KimWB, KimD, OhU. Capsaicin binds to the intracellular domain of the capsaicin-activated ion channel. J Neurosci, 19:529–538. 1999.
136.
KaganVE, ArroyoA, TyurinVA, TyurinaYY, VillalbaJM, NavasP. Plasma membrane NADH-coenzyme Q0 reductase generates semiquinone radicals and recycles vitamin E homologue in a superoxide-dependent reaction. FEBS Lett, 428:43–46. 1998.
137.
KamataT. Roles of Nox1 and other Nox isoforms in cancer development. Cancer Sci, 100:1382–1388. 2009.
138.
KarplusPA, DanielsMJ, HerriottJR. Atomic structure of ferredoxin-NADP+reductase: prototype for a structurally novel flavoenzyme family. Science, 251:60–66. 1991.
139.
KawaharaT, TeshimaS, OkaA, SugiyamaT, KishiK, RokutanK. Type I Helicobacter pylori lipopolysaccharide stimulates toll-like receptor 4 and activates mitogen oxidase 1 in gastric pit cells. Infect Immun, 69:4382–4389. 2001.
140.
KelkerM, KimC, ChuehP-J, GuimontR, MorréDM, MorréDJ. Cancer isoform of a tumor-associated cell surfaceNADHoxidase (tNOX) has properties of a prion. Biochemistry, 40:7351–7354. 2001.
141.
KennettEC, KuchelPW. Plasma membrane oxidoreductases: effects on erythrocyte metabolism and redox homeostasis. Antioxid Redox Signal, 8:1241–1247. 2006.
142.
KennettEC, KuchelPW. Redox reactions and electron transfer across the red cell membrane. IUBMB Life, 55:375–385. 2003.
143.
KennettEC, OgawaE, AgarNS, GodwinIR, BubbWA, KuchelPW. Investigation of methaemoglobin reduction by extracellular NADH in mammalian erythrocytes. Int J Biochem Cell Biol, 37:1438–1445. 2005.
144.
KernDG, DraelosZD, MeadowsC, MorréDJ, MorréDM. Controlling reactive oxygen species in skin at their source to reduce skin aging. Rejuvenation Res, 13:1–3. 2010.
145.
KeyesSR, CintiDL. Biochemical properties of cytochrome c-dependent microsomal fatty acid elongation and identification of products. J Biol Chem, 255:11357–11364. 1980.
146.
KikuchiH, HikageM, MiyashitaH, FukumotoM. NADPH oxidase subunit, gp91(phox) homologue, preferentially expressed in human colon epithelial cells. Gene, 254:237–243. 2000.
147.
KilbergMS, ChristensenHN. Electron-transferring enzymes in the plasma membrane of the Ehrlich ascites tumor cell. Biochemistry, 18:1525–1530. 1979.
148.
KimC, MacKellarWC, ChoN, ByrnSR, MorréDJ. Impermeant antitumor sulfonylurea conjugates that inhibit plasma membrane NADH oxidase and growth of HeLa cells in culture. Identification of binding proteins from sera of cancer patients. Biochim Biophys Acta, 1324:171–181. 1997.
149.
KimJS, DieboldBA, BabiorBM, KnausUG, BokochGM. Regulation of Nox1 activity via protein kinase A-mediated phosphorylation of NoxA1 and 14-3-3 binding. J Biol Chem, 282:34787–34800. 2007.
150.
KimuraS, KawamuraM, IyanagiT. Role of Thr(66) in porcine NADH-cytochrome b5 reductase in catalysis and control of the rate-limiting step in electron transfer. J Biol Chem, 278:3580–2589. 2003.
151.
KinnulaVL. Production and degradation of oxygen metabolites during inflammatory states in the human lung. Curr Drug Targets Inflamm Allergy, 2:465–470. 2005.
152.
KishiT, MorréDM, MorréDJ. The plasma membrane NADH oxidase of HeLa cells has hydroquinone oxidase activity. Biochim Biophys Acta, 1412:66–77. 1999.
153.
KishidaKT, HoefferCA, HuD, PaoM, HollandSM, KlannE. Synaptic plasticity deficits and mild memory impairments in mouse models of chronic granulomatous disease. Mol Cell Biol, 26:5908–5920. 2006.
154.
KrauskopfA, ErikssonO, CraigenWJ, ForteMA, BernardiP. Properties of the permeability transition in VDAC1(−/−) mitochondria. Biochim Biophys Acta, 1757:590–595. 2006.
155.
KurianJR, BajadSU, MillerJL, ChinNA, TrepanierLA. NADH cytochrome b5 reductase and cytochrome b5 catalyze the microsomal reduction of xenobiotic hydroxylamines and amidoximes in humans. J Pharmacol Exp Ther, 311:1171–1178. 2004.
156.
KurokawaM, KornbluthS. Caspases and kinases in a death grip. Cell, 138:838–854. 2009.
157.
LaneDJ, LawenA. Ascorbate and plasma membrane electron transport—enzymes vs efflux. Free Radic Biol Med, 47:485–495. 2009.
158.
LaneDJ, LawenA. Transplasma membrane electron transport comes in two flavors. Biofactors, 34:191–200. 2009.
159.
LaneDJ, RobinsonSR, CzerwinskaH, LawenA. A role for Na+/H+ exchangers and intracellular pH in regulating vitamin C-driven electron transport across the plasma membrane. Biochem J, 428:191–200. 2010.
160.
LaneDJR, LawenA. Non-transferrin iron reduction and uptake are regulated by transmembrane ascorbate cycling in K562 cells. J Biol Chem, 283:12701–12708. 2008.
161.
LarmJA, VaillantF, LinnaneAW, LawenA. Up-regulation of the plasma membrane oxidoreductase as a prerequisite for the viability of human Namalwa rho 0 cells. J Biol Chem, 269:30097–30100. 1994.
162.
LassA, ForsterMJ, SohalRS. Effects of coenzyme Q10 and alphatocopherol administration on their tissue levels in the mouse: elevation of mitochondrial alpha-tocopherol by coenzyme Q10. Free Radical Biol Med, 26:1375–1382. 1999.
163.
LaurentE, McCoyJW3rd, MacinaRA, LiuW, ChengG, RobineS, PapkoffJ, LambethJD. Nox1 is over-expressed in human colon cancers and correlates with activating mutations in K-Ras. Int J Cancer, 123:100–107. 2008.
164.
LawenA, LyJD, LaneDJ, ZarschlerK, MessinaA, De PintoV. Voltage-dependent anion-selective channel 1 (VDAC1)—a mitochondrial protein, rediscovered as a novel enzyme in the plasma membrane. Int J Biochem Cell Biol, 37:277–282. 2005.
LeeS, LiR, KimB, PalvolgyiR, HoT, YangQ-Z, XuJ, SzetoWL, HondaH, BerlinerJA. Ox-PAPC activation of PMET system increases expression of heme oxygenase-1 in human aortic endothelial cell. J Lipid Res, 50:265–274. 2009.
167.
LeeYM, KimBJ, ChunYS, SoI, ChoiH, KimMS, ParkJW. NOX4 as an oxygen sensor to regulate TASK-1 activity. Cell Signal, 18:499–507. 2006.
168.
LenazG, PaolucciU, FatoR, D'AurelioM, Parenti CastelliG, SgarbiG, BiaginiG, RagniL, SalardiS, CacciariE. Enhanced activity of the plasma membrane oxidoreductase in circulating lymphocytes from insulin-dependent diabetes mellitus patients. Biochem Biophys Res Commun, 290:1589–1592. 2002.
169.
LewisIA, CampanellaME, MarkleyJL, LowPS. Role of band 3 in regulating metabolic flux of red blood cells. Proc Natl Acad Sci U S A, 106:18515–18520. 2009.
170.
LiR, BianchetMA, TalalayP, AmzelLM. The three-dimensional structure of NAD(P)H:quinone reductase, a flavoprotein involved in cancer chemoprotection and chemotherapy: mechanism of the two-electron reduction. Proc Natl Acad Sci U S A, 92:8846–8850. 1995.
171.
LinSJ, GuarenteL. Nicotinamide adenine dinucleotide, a metabolic regulator of transcription, longevity and disease. Curr Opin Cell Biol, 15:241–246. 2003.
LiuSC, YangJJ, ShaoKN, ChuehPJ. RNA interference targeting tNOX attenuates cell migration via a mechanism that involves membrane association of Rac. Biochem Biophys Res Commun, 365:672–677. 2008.
174.
Lopez-LluchG, RiosM, LaneMA, NavasP, de CaboR. Mouse liver plasma membrana redox system activity is altered by aging and modulated by calorie restriction. AGE, 27:153–160. 2005.
175.
LudwiczekS, RosellFI, LudwiczekML, MaukAG. Recombinant expression and initial characterization of the putative human enteric ferric reductase Dcytb. Biochemistry, 47:753–761. 2008.
176.
LuxenS, BelinskySA, KnausUG. Silencing of DUOX NADPH oxidases by promoter hypermethylation in lung cancer. Cancer Res, 68:1037–1045. 2008.
177.
LyJD, LawenA. Transplasma membrane electron transport: enzymes involved and biological function. Redox Rep, 8:3–21. 2003.
178.
MachoA, CalzadoMA, Munoz-BlancoJ, Gomez-DiazC, GajateC, MollinedoF, NavasP, MuñozE. Selective induction of apoptosis by capsaicin in transformed cells: the role of reactive oxygen species and calcium. Cell Death Differ, 6:155–165. 1999.
179.
MachoA, LucenaC, CalzadoMA, BlancoM, DonnayI, AppendinoG, MuñozE. Phorboid 20-homovanillates induce apoptosis through a VR1-independent mechanism. Chem Biol, 7:483–492. 2000.
180.
MadeshM, HajnoczkyG. VDAC-dependent permeabilization of the outer mitochondrial membrane by superoxide induces rapid and massive cytochrome c release. J Cell Biol, 155:1003–1016. 2001.
181.
MangiulloR, GnoniA, LeoneA, GnoniGV, PapaS, ZanottiF. Structural and functional characterization of F(o)F(1)-ATP synthase on the extracellular surface of rat hepatocytes. Biochim Biophys Acta, 1777:1326–1335. 2008.
182.
MarguttiP, MatarreseP, ContiF, ColasantiT, DelunardoF, CapozziA, GarofaloT, ProfumoE, RiganòR, SiracusanoA, AlessandriC, SalvatiB, ValesiniG, MalorniW, SoriceM, OrtonaE. Autoantibodies to the C-terminal subunit of RLIP76 induce oxidative stress and endothelial cell apoptosis in immune-mediated vascular diseases and atherosclerosis. Blood, 111:4559–4570. 2008.
183.
MarquesF, CrespoME, BichoM. Control of NADH ferricyanide reductase activity in the human erythrocyte by somatotrophin and insulin. Redox Rep, 1:113–117. 1995.
184.
MartínSF, Gómez-DíazC, BelloRI, NavasP, VillalbaJM. Inhibition of neutral Mg2+-dependent sphingomyelinase by ubiquinol-mediated plasma membrane electron transport. Protoplasma, 221:109–116. 2003.
185.
MartínSF, NavarroF, ForthofferN, NavasP, VillalbaJM. Neutral magnesium-dependent sphingomyelinase from liver plasma membrane: purification and inhibition by ubiquinol. J Bioenerg Biomembr, 33:143–153. 2001.
186.
Martín-RomeroFJ, García-MartínE, Gutiérrez-MerinoC. Inhibition of oxidative stress produced by plasma membrane NADH oxidase delays low-potassium-induced apoptosis of cerebellar granule cells. J Neurochem, 82:705–715. 2002.
187.
Martın-RomeroFJ, Gutierrez-MartınY, HenaoF, Gutierrez-MerinoC. The NADH oxidase activity of the plasma membrane of synaptosomes is a major source of superoxide anion and is inhibited by peroxynitrite. J Neurochem, 82:604–614. 2002.
188.
MathupalaSP, PedersenPL.Voltage dependent anion channel-1 (VDAC-1) as an anti-cancer target. Cancer Biol Ther, 9:1053–1056. 2010.
189.
MatsushitaH, LeeK, TsaoPS. Cyclic strain induces reactive oxygen species production via an endothelial NAD(P)H oxidase. J Cell Biochem, 81:99–106. 2001.
190.
MatteucciE, CupistiA, CaprioliR, BattipagliaE, FavillaS, RindiP, BarsottiG, GiampietroO. Erythrocyte transmembrane electron transfer in haemodialysis patients. Nutr Metab Cardiovasc Dis, 17:288–293. 2007.
191.
MayJM, QuZ-C, MendirattaS. Protection and recycling of a-tocopherol in human erythrocytes by intracellular ascorbic acid. Arch Biochem Biophys, 349:281–289. 1998.
192.
MayJM, QuZC, NelsonDJ. Uptake and reduction of α-lipoic acid by human erythrocytes. Clin Biochem, 40:1135–1142. 2007.
193.
MayJM, QuZ-C, WhitesellRR. Ascorbic acid recycling enhances the antioxidant reserve of human erythrocytes. Biochemistry, 34:12721–12728. 1995.
194.
MayJM. Is ascorbic acid an antioxidant for the plasma membrane?FASEB J, 13:995–1006. 1999.
McKieAT, BarrowD, Latunde-DadaGO, RolfsA, SagerG, MudalyE, MudalyM, RichardsonC, BarlowD, BomfordA, PetersTJ, RajaKB, ShiraliS, HedigerMA, FarzanehF, SimpsonRJ. An iron-regulated ferric reductase associated with the absorption of dietary iron. Science, 291:1755–1759. 2001.
197.
McKieAT. The role of Dcytb in iron metabolism: an update. Biochem Soc Trans, 36:1239–1241. 2008.
198.
MessanaI, OrlandoM, CassianoL, PennacchiettiL, ZuppiC, CastagnolaM, GiardinaB. Human erythrocyte metabolism is modulated by the O2-linked transition of hemoglobin. FEBS Lett, 390:25–28. 1996.
199.
MitsushitaJ, LambethJD, KamataT. The superoxide-generating oxidase Nox1 is functionally required for Ras oncogene transformation. Cancer Res, 64:3580–3585. 2004.
MochizukiT, FurutaS, MitsushitaJ, ShangWH, ItoM, YokooY, YamauraM, IshizoneS, NakayamaJ, KonagaiA, HiroseK, KiyosawaK, KamataT. Inhibition of NADPH oxidase 4 activates apoptosis via the AKT/apoptosis signal-regulating kinase 1 pathway in pancreatic cancer PANC-1 cells. Oncogene, 25:3699–3707. 2006.
202.
MorenoJC, BikkerH, KempersMJ, van TrotsenburgAS, BaasF, de VijlderJJ, VulsmaT, Ris-StalpersC. Inactivating mutations in the gene for thyroid oxidase 2 (THOX2) and congenital hypothyroidism. N Engl J Med, 347:95–102. 2002.
MorréDJ, MorréDM. Aging-related cell surface ECTO-NOX protein, arNOX, a preventive target to reduce atherogenic risk in the elderly. Rejuvenation Res, 9:231–236. 2006.
205.
MorréDJ, MorréDM. Cell surface NADH oxidases (ECTO-NOX proteins) with roles in cancer, cellular time-keeping, growth, aging and neurodegenerative diseases. Free Radic Res, 37:795–808. 2003.
206.
MorréDJ, ChuehP-J, LawlerJ, MorréDM. The sulfonylurea-inhibited NADH oxidase activity of HeLa cell plasma membranes has properties of a protein disulfide–thiol oxidoreductase with protein disulfide–thiol interchange activity. J Bioenerg Biomembr, 30:477–487. 1998.
207.
MorréDJ, ChuehP-J, PletcherJ, TangX, WuL-Y, MorréDM. Biochemical basis for the biological clock. Biochemistry, 41:11941–11945. 2002.
208.
MorréDJ, HostetlerB, WestonN, KimC, MorréDM. Cancer type-specific tNOX isoforms: a putative family of redox protein splice variants with cancer diagnostic and prognostic potential. Biofactors, 34:201–207. 2009.
209.
MorréDJ, OrczykJ, HigniteH, KimC. Regular oscillatory behavior of aqueous solutions of CuII salts related to effects on equilibrium dynamics of ortho/para hydrogen spin isomers of water. J Inorg Biochem, 102:260–267. 2008.
210.
MorréDJ, SunE, GeilenC, WuL-Y, de CaboR, KrasagakisK, OrfanosCE, MorréDM. Capsaicin inhibits plasma membrane NADH oxidase and growth of human and mouse melanoma lines. Eur J Cancer, 32:1995–2003. 1996.
211.
MorréDJ. NADH oxidase activity of HeLa plasma membranes inhibited by the antitumor sulfonylurea N-(4-methylphenylsulfonyl)-N0-(4-chlorophenyl)urea (LY181984) at an external site. Biochim Biophys Acta, 1240:201–208. 1995.
212.
MorréDM, MorréDJ. Specificity of coenzyme Q inhibition of an aging-related cell surface NADH oxidase (ECTO-NOX) that generates superoxide. Biofactors, 18:33–43. 2003.
213.
MorréDM, GuoF, MorréDJ. An aging-related cell surface NADH oxidase (arNOX) generates superoxide and is inhibited by coenzyme Q. Mol Cell Biochem, 254:101–109. 2003.
214.
MorréDM, MorréDJ, RehmusW, KernD. Supplementation with CoQ10 lowers age-related (ar) NOX levels in healthy subjects. Biofactors, 32:221–230. 2008.
215.
NauseefWM. Biological roles for the NOX family NADPH oxidases. J Biol Chem, 283:16961–16965. 2008.
216.
NavarroF, NavasP, BurgessJR, BelloRI, De CaboR, ArroyoA, VillalbaJM. Vitamin E and selenium deficiency induces expression of the ubiquinone-dependent antioxidant system at the plasma membrane. FASEB J, 12:1665–1673. 1998.
217.
NavasP, VillalbaJM, de CaboR. The importance of plasma membrane coenzyme Q in aging and stress responses. Mitochondrion, 7:S34–S40. 2007.
218.
NishidaH, InakaK, YamanakaM, KaidaS, KobayashiK, MikiK. Crystal structure of NADH-cytochrome b5 reductase from pig liver at 2.4 A resolution. Biochemistry, 34:2763–2767. 1995.
219.
NolanKA, DoncasterJR, DunstanMS, ScottKA, FrenkelAD, SiegelD, RossD, BarnesJ, LevyC, LeysD, WhiteheadRC, StratfordIJ, BryceRA. Synthesis and biological evaluation of coumarin-based inhibitors of NAD(P)H: quinone oxidoreductase-1 (NQO1)J Med Chem, 52:7142–7156. 2009.
220.
Nozik-GrayckE, PiantadosiCA, van AdelsbergJ, AlperSL, HuangYCT. Protection of perfused lung from oxidant injury by inhibitors of anion exchange. Am J Physiol Lung Cell Mol Physiol, 273:L296–L304. 1997.
221.
NutterLM, NgoEO, FisherGR, GutierrezPL. DNA strand scission and free radical production in menadione-treated cells. Correlation with cytotoxicity and role of NADPH quinone acceptor oxidoreductase. J Biol Chem, 267:2474–2479. 1992.
222.
OakhillJS, MarrittSJ, GaretaEG, CammackR, McKieAT. Functional characterization of human duodenal cytochrome b (Cybrd1): redox properties in relation to iron and ascorbate metabolism. Biochim Biophys Acta, 1777:260–268. 2008.
223.
OkunJG, LummenP, BrandtU. Three classes of inhibitors share a common binding domain in mitochondrial complex I (NADH:ubiquinone oxidoreductase)J Biol Chem, 274:2625–2630. 1999.
224.
OrringerEP, RoerME. An ascorbate-mediated transmembrane-reducing system of the human erythrocyte. J Clin Invest, 63:53–58. 1979.
225.
OshinoN, ImaiY, SatoR. A function of cytochrome b5 in fatty acid desaturation by rat liver microsomes. J Biochem (Tokyo), 69:155–167. 1971.
226.
OzolsJ, CarrSA, StrittmatterP. Identification of the NH2-terminal blocking group of NADH-cytochrome b5 reductase as myristic acid and the complete amino acid sequence of the membrane-binding domain. J Biol Chem, 259:13349–13354. 1984.
227.
PachuckiJ, WangD, ChristopheD, MiotF. Structural and functional characterization of the two human ThOX/Duox genes and their 5'-flanking regions. Mol Cell Endocrinol, 214:53–62. 2004.
228.
PaffenholzR, BergstromRA, PasuttoF, WabnitzP, MunroeRJ, JaglaW, HeinzmannU, MarquardtA, BareissA, LaufsJ, RussA, StummG, SchimentiJC, BergstromDE. Vestibular defects in head-tilt mice result from mutations in Nox3, encoding an NADPH oxidase. Genes Dev, 18:486–491. 2004.
229.
PalmingJ, SjoholmK, JernasM, LystigTC, GummessonA, RomeoS, LonnL, LonnM, CarlssonB, CarlssonLM. The expression of NAD(P)H:quinone oxidoreductase 1 is high in human adipose tissue, reduced by weight loss, and correlates with adiposity, insulin sensitivity, and markers of liver dysfunction. J Clin Endocrinol Metab, 92:2346–2352. 2007.
230.
PaoM, WiggsEA, AnastacioMM, HyunJ, DeCarloES, MillerJT, AndersonVL, MalechHL, GallinJI, HollandSM. Cognitive function in patients with chronic granulomatous disease: a preliminary report. Psychosomatics, 45:230–234. 2004.
231.
ParkL, ZhouP, PitstickR, CaponeC, AnratherJ, NorrisEH, YounkinL, YounkinS, CarlsonG, McEwenBS, IadecolaC. Nox2-derived radicals contribute to neurovascular and behavioral dysfunction in mice overexpressing the amyloid precursor protein. Proc Natl Acad Sci U S A, 105:1347–1352. 2008.
232.
ParkosCA, AllenRA, CochraneCG, JesaitisAJ. Purified cytochrome b from human granulocyte plasma membrane is comprised of two polypeptides with relative molecular weights of 91,000 and 22,000. J Clin Invest, 80:732–742. 1987.
233.
PassonPG, HultquistDE. Soluble cytochrome b 5 reductase from human erythrocytes. Biochim Biophys Acta, 275:62–73. 1972.
234.
PelicanoH, XuR, DuM, FengL, SasakiR, CarewJS, HuY, RamdasL, HuL, KeatingMJ, ZhangW, PlunkettW, HuangP. Mitochondrial respiration defects in cancer cells cause activation of Akt survival pathway through a redox mediated mechanism. J Cell Biol, 175:913–923. 2006.
RaghuG, WeyckerD, EdelsbergJ, BradfordWZ, OsterG. Incidence and prevalence of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med, 174:810–816. 2006.
241.
ReddyVV, KupferD, CapsiE. Mechanism of C-5 double bond introduction in the biosynthesis of cholesterol by rat liver microsomes. J Biol Chem, 252:2797–2801. 1977.
242.
RivlinJ, MendelJ, RubinsteinS, EtkovitzN, BreitbartH. Role of hydrogen peroxide in sperm capacitation and acrosome reaction. Biol Reprod, 70:518–522. 2004.
243.
RizviSI, JhaR, MauryaPK. Erythrocyte plasma membrane redox system in human aging. Rejuvenation Res, 9:470–474. 2006.
244.
Rodríguez-AlonsoJ, MontañezR, Rodríguez-CasoL, MedinaMA. Homocysteine is a potent modulator of plasma membrane electron transport systems. J Bioenerg Biomembr, 40:45–51. 2008.
245.
RogersSC, SaidA, CorcueraD, McLaughlinD, KellP, DoctorA. Hypoxia limits antioxidant capacity in red blood cells by altering glycolytic pathway dominance. FASEB J, 23:3159–3170. 2009.
246.
RossiF, ZattiM. Biochemical aspects of phagocytosis in polymorphonuclear leucocytes. NADH and NADPH oxidation by the granules of resting and phagocytizing cells. Experientia, 20:21–23. 1964.
247.
RubinsteinB, LusterDG. Plasma membrane redox activity: components and role in plant processes. Ann Rev Plant Physiol Plant Mol Biol, 44:131–155. 1993.
248.
SabeurK, BallBA. Characterization of NADPH oxidase 5 in equine testis and spermatozoa. Reproduction, 134:263–267. 2007.
Samhan-AriasAK, DuarteRO, Martín-RomeroFJ, MouraJJ, Gutiérrez-MerinoC. Reduction of ascorbate free radical by the plasma membrane of synaptic terminals from rat brain. Arch Biochem Biophys, 469:243–254. 2008.
251.
Samhan-AriasAK, Garcia-BereguiainMA, Martin-RomeroFJ, Gutierrez-MerinoC. Clustering of plasma membrane-bound cytochrome b5 reductase within “lipid raft” microdomains of the neuronal plasma membrane. Mol Cell Neurosci, 40:14–26. 2009.
252.
SánchezAM, Malagarie-CazenaveS, OleaN, VaraD, ChiloechesA, Díaz-LaviadaI. Apoptosis induced by capsaicin in prostate PC-3 cells involves ceramide accumulation, neutral sphingomyelinase, and JNK activation. Apoptosis, 12:2013–2024. 2007.
253.
SaviniI, ArnoneR, RossiA, CataniMV, Del PrincipeD, AviglianoL. Redox modulation of Ecto-NOX1 in human platelets. Mol Membr Biol, 27:160–169. 2010.
254.
SaviniI, CataniMV, ArnoneR, RossiA, FregaG, Del PrincipeD, AviglianoL. Translational control of the ascorbic acid transporter SVCT2 in human platelets. Free Radic Biol Med, 42:608–616. 2007.
255.
ScarlettDJ, HerstP, TanA, PrataC, BerridgeM. Mitochondrial gene-knockout (rho0) cells: a versatile model for exploring the secrets of trans-plasma membrane electron transport. Biofactors, 20:199–206. 2004.
256.
ScarlettDJ, HerstPM, BerridgeMV. Multiple proteins with single activities or a single protein with multiple activities: the conundrum of cell surface NADH oxidoreductases. Biochim Biophys Acta, 1708:108–119. 2005.
257.
ScholzRW, MinicucciLA, ReddyCC. Effects of vitamin E and selenium on antioxidant defense in rat heart. Biochem. Mol Biol Int, 42:997–1006. 1997.
SchulzeU, SchottH, StaudingerH. Isolierung und charakterisierung einer NADH:semidehydroascorbinsaure-oxidoreduktase aus Neurospora crassa. Hoppe-Seyler's Z Physiol Chem, 353:1931–1942. 1972.
260.
ScottEM, GriffithIV. The enzymic defect of hereditary methemoglobinemia: diaphorase. Biochim Biophys Acta, 34:584–586. 1959.
261.
SeigelD, GustafsonDL, DehnDL, HanJY, BoonchoongP, BerlinerLJ, RossD. NAD(P)H:quinone oxidoreductase 1: role as a superoxide scavenger. Mol Pharmacol, 65:1238–1247. 2004.
262.
SemenzaGL. Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics. Oncogene, 29:625–634. 2010.
263.
SemenzaGL. Regulation of cancer cell metabolism by hypoxia-inducible factor 1. Semin Cancer Biol, 19:12–16. 2009.
264.
SenoT, InoueN, GaoD, OkudaM, SumiY, MatsuiK, YamadaS, HirataKI, KawashimaS, TawaR, Imajoh-OhmiS, SakuraiH, YokoyamaM. Involvement of NADH/NADPH oxidase in human platelet ROS production. Thromb Res, 103:399–409. 2001.
265.
SerranderL, CartierL, BedardK, BanfiB, LardyB, PlastreO, SienkiewiczA, FórróL, SchlegelW, KrauseKH. NOX4 activity is determined by mRNA levels and reveals a unique pattern of ROS generation. Biochem J, 406:105–114. 2007.
266.
ShimizuS, MatsuokaY, ShinoharaY, YonedaY, TsujimotoY. Essential role of voltage-dependent anion channel in various forms of apoptosis in mammalian cells. J Cell Biol, 152:237–250. 2001.
267.
ShimizuS, NaritaM, TsujimotoY. BcL-2 family proteins regulate the release of apoptogenic cytochrome c by the mitochondrial channel VDAC. Nature, 399:483–487. 1999.
268.
ShinoharaM, ShangWH, KuboderaM, HaradaS, MitsushitaJ, KatoM, MiyazakiH, SumimotoH, KamataT. Nox1 redox signaling mediates oncogenic Ras-induced disruption of stress fibers and focal adhesions by down-regulating Rho. J Biol Chem, 282:17640–17648. 2007.
ShirabeK, LandiMT, TakeshitaM, UzielG, FedrizziE, BorgeseN. A novel point mutation in a 3' splice site of the NADH-cytochrome b5 reductase gene results in immunologically undetectable enzyme and impaired NADH-dependent ascorbate regeneration in cultured fibroblasts of a patient with type II hereditary methemoglobinemia. Am J Hum Genet, 57:302–310. 1995.
271.
ShuklaS, JhaRK, LalorayaM, KumarPG. Identification of nonmitochondrial NADPH oxidase and the spatio-temporal organization of its components in mouse spermatozoa. Biochem Biophys Res Commun, 331:476–483. 2005.
272.
SongY, RufJ, LothaireP, DequanterD, AndryG, WillemseE, DumontJE, Van SandeJ, De DekenX. Association of duoxes with thyroid peroxidase and its regulation in thyrocytes. J Clin Endocrinol Metab, 95:375–382. 2010.
273.
StasiaMJ, LiXJ. Genetics and immunopathology of chronic granulomatous disease. Semin Immunopathol, 30:209–235. 2008.
274.
StrittmatterP. The reaction sequence in electron transfer in the reduced nicotinamide adenine dinucleotide-cytochrome b5 reductase system. J Biol Chem, 240:4481–4487. 1965.
275.
SuD, AsardH. Three mammalian cytochromes b561 are ascorbate-dependent ferrireductases. FEBS J, 273:3722–3734. 2006.
276.
SuD, MayJM, KouryMJ, AsardH. Human erythrocyte membranes contain a cytochrome b561 that may be involved in extracellular ascorbate recycling. J Biol Chem, 281:39852–39859. 2006.
277.
SuhYA, ArnoldRS, LassegueB, ShiJ, XuX, SorescuD, ChungAB, GriendlingKK, LambethJD. Cell transformation by the superoxide-generating oxidase Mox1. Nature, 401:79–82. 1999.
278.
SumimotoH, HataK, MizukiK, ItoT, KageY, SakakiY, FukumakiY, NakamuraM, TakeshigeK. Assembly and activation of the phagocyte NADPH oxidase. Specific interaction of the N-terminal Src homology 3 domain of p47phox with p22phox is required for activation of the NADPH oxidase. J Biol Chem, 271:22152–22158. 1996.
279.
SumimotoH. Structure, regulation and evolution of Nox-family NADPH oxidases that produce reactive oxygen species. FEBS J, 275:3249–3277. 2008.
280.
TabetF, SchiffrinEL, CalleraGE, HeY, YaoG, OstmanA, KappertK, TonksNK, TouyzRM. Redox-sensitive signaling by angiotensin II involves oxidative inactivation and blunted phosphorylation of protein tyrosine phosphatase SHP-2 in vascular smooth muscle cells from SHR. Circ Res, 103:149–158. 2008.
281.
TanAS, BerridgeMV. Superoxide produced by activated neutrophils efficiently reduces the tetrazolium salt WST-1 to produce a soluble formazan: a simple colorimetric assay for measuring respiratory burst activation and for screening anti-inflammatory agents. J Immunol Methods, 238:59–68. 2000.
282.
TanAS, BerridgeMV. Distinct trans-plasma membrane redox pathways reduce cell-impermeable dyes in HeLa cells. Redox Rep, 9:302–306. 2004.
283.
TanAS, BerridgeMV. Differential effects of redox-cycling and arylating quinones on trans-plasma membrane electron transport. Biofactors, 34:183–190. 2009.
284.
TanAS, BerridgeMV. Evidence for NAD(P)H:quinone oxidoreductase 1 (NQO1)-mediated quinone-dependent redox cycling via plasma membrane electron transport: A sensitive cellular assay for NQO1. Free Radic Biol Med, 48:421–429. 2010.
285.
ThinnesFP. Evidence for extra-mitochondrial localization of the VDAC/porin channel in eucaryotic cells. J Bioenerg Biomembr, 24:71–75. 1992.
286.
TironeF, CoxJA. NADPH oxidase 5 (NOX5) interacts with and is regulated by calmodulin. FEBS Lett, 581:1202–1208. 2007.
287.
TomatsuS, KobayashiY, FukumakiY, YubisuiT, OriiT, SakakiY. The organization and the complete nucleotide sequence of the human NADH-cytochrome b5 reductase gene. Gene, 80:353–361. 1989.
288.
TominagaK, KawaharaT, SanoT, ToidaK, KuwanoY, SasakiH, KawaiT, Teshima-KondoS, RokutanK. Evidence for cancer-associated expression of NADPH oxidase 1 (Nox1)-based oxidase system in the human stomach. Free Radic Biol Med, 43:1627–1638. 2007.
289.
TouyzRM, SchiffrinEL. Increased generation of superoxide by angiotensin II in smooth muscle cells from resistance arteries of hypertensive patients: role of phospholipase D-dependent NAD(P)H oxidase-sensitive pathways. J Hypertens, 19:1245–1254. 2001.
290.
TranUC, ClarkeCF. Endogenous synthesis of coenzyme Q in eukaryotes. Mitochondrion, 7:S62–S71. 2007.
291.
TsujimotoY, ShimizuS. Role of the mitochondrial membrane permeability transition in cell death. Apoptosis, 12:835–840. 2007.
292.
TsunawakiS, KagaraS, YoshikawaK, YoshidaLS, KuratsujiT, NamikiH. Involvement of p40phox in activation of phagocyte NADPH oxidase through association of its carboxyl-terminal, but not its amino-terminal, with p67phox. J Exp Med, 184:893–902. 1996.
293.
TuriJL, WangX, McKieAT, Nozik-GrayckE, MamoLB, CrissmanK, PiantadosiCA, GhioAJ. Duodenal cytochrome b: a novel ferrireductase in airway epithelial cells. Am J Physiol Lung Cell Mol Physiol, 291:L272–L280. 2006.
294.
UenoN, TakeyaR, MiyanoK, KikuchiH, SumimotoH. The NADPH oxidase Nox3 constitutively produces superoxide in a p22phox-dependent manner: its regulation by oxidase organizers and activators. J Biol Chem, 280:23328–23339. 2005.
295.
UkaiH, UedaHR. Systems biology of mammalian circadian clocks. Annu Rev Physiol, 72:579–603. 2010.
296.
Ushio-FukaiM. VEGF signaling through NADPH oxidase-derived ROS. Antioxid Redox Signal, 9:731–739. 2007.
297.
Ushio-FukaiM, ZafariAM, FukuiT, IshizakaN, GriendlingKK. p22phox is a critical component of the superoxide-generating NADH/NADPH oxidase system and regulates angiotensin II-induced hypertrophy in vascular smooth muscle cells. J Biol Chem, 271:23317–23321. 1996.
298.
Vander HeidenMG, CantleyLC, ThompsonCB. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science, 324:1029–1033. 2009.
299.
VanDuijnMM, Van der ZeeJ, Van den BroekPJ. The ascorbate-driven reduction of extracellular ascorbate free radical by the erythrocyte is an electrogenic process. FEBS Lett, 491:67–70. 2001.
300.
VernetP, FultonN, WallaceC, AitkenRJ. Analysis of reactive oxygen species generating systems in rat epididymal spermatozoa. Biol Reprod, 65:1102–1113. 2001.
301.
VillalbaJM, NavarroF, CórdobaF, SerranoA, ArroyoA, CraneFL, NavasP. Coenzyme Q reductase from liver plasma membrane: purification and role in trans-plasma-membrane electron transport. Proc Natl Acad Sci U S A, 92:4887–4891. 1995.
302.
VillalbaJM, NavarroF, Gomez-DıazC, ArroyoA, BelloRI, NavasP. Role of cytochrome b5 reductase on the antioxidant function of coenzyme Q in the plasma membrane. Mol Aspects Med, 18:S7–S13. 1997.
303.
VioraM, QuarantaMG, StrafaceE, VariR, MasellaR, MalorniW. Redox imbalance and immune functions: opposite effects of oxidized low-density lipoproteins and N-acetylcysteine. Immunology, 104:431–438. 2001.
304.
VoegtlinC, JohnsonJM, DyerHA.Jr. Quantitative estimation of the reducing power of normal and cancer tissue. J Pharmacol Exp Ther, 24:305–334. 1925.
305.
WangC, YouleRJ. The role of mitochondria in apoptosis. Annu Rev Genet, 43:95–118. 2009.
306.
WangHM, ChuehPJ, ChangSP, YangCL, ShaoKN. Effect of capsaicin on tNOX (ENOX2) protein expression in stomach cancer cells. Biofactors, 34:209–217. 2009.
307.
WangS, MorréDM, MorréDJ. Sera from cancer patients contain two oscillating ECTO-NOX activities with different period lengths. Cancer Lett, 190:135–141. 2003.
308.
WangS, PogueR, MorréDM, MorréDJ. NADH oxidase activity (NOX) and enlargement of HeLa cells oscillate with two different temperature-compensated period lengths of 22 and 24 minutes corresponding to different NOX forms. Biochim Biophys Acta, 1539:192–204. 2001.
309.
WarburgO. The Metabolism of Tumors. London: Constable & Co, 1930.
310.
WesleyUV, BovePF, HristovaM, McCarthyS, van der VlietA. Airway epithelial cell migration and wound repair by ATP-mediated activation of dual oxidase 1. J Biol Chem, 282:3213–3220. 2007.
311.
WilkinsonF, KimC, ChoN, ChuehP-J, LeslieS, Moya-CamarenaS, WuL-Y, MorréDJ, MorréDM. Isolation and identification of a protein with capsaicin-inhibited NADHoxidase activity from culture media conditioned by growth of HeLa cells. Arch Biochem Biophys, 336:275–282. 1996.
312.
WolvetangEJ, LarmJA, MoutsoulasP, LawenA. Apoptosis induced by inhibitors of the plasma membrane NADH-oxidase involves Bcl-2 and calcineurin. Cell Growth Differ, 7:1315–1325. 1996.
313.
WongJL, CrétonR, WesselGM. The oxidative burst at fertilization is dependent upon activation of the dual oxidase Udx1. Dev Cell, 7:801–814. 2004.
314.
WymanS, SimpsonRJ, McKieAT, SharpPA. Dcytb (Cybrd1) functions as both a ferric and a cupric reductase in vitro. FEBS Lett, 582:1901–1906. 2008.
315.
YagizK, WuLY, KuntzCP, James MorréD, MorréDM. Mouse embryonic fibroblast cells from transgenic mice overexpressing tNOX exhibit an altered growth and drug response phenotype. J Cell Biochem, 101:295–306. 2007.
316.
YantiriF, MorréDJ, YagizK, BarogiS, WangS, ChuehPJ, ChoN, SedlakD, MorréDM. Capsaicin-responsive NADH oxidase activities from urine of cancer patients. Arch Biochem Biophys, 358:336–342. 1998.
317.
YingW. NAD+/NADH and NADP+/NADPH in cellular functions and cell death: regulation and biological consequences. Antioxid Redox Signal, 10:179–206. 2008.
318.
ZaidH, Abu-HamadS, IsraelsonA, NathanI, Shoshan-BarmatzV. The voltage-dependent anion channel-1 modulates apoptotic cell death. Cell Death Differ, 12:751–760. 2005.
319.
ZainalTA, OberleyTD, AllisonDB, SzwedaLI, WeindruchR. Caloric restriction of rhesus monkeys lowers oxidative damage in skeletal muscle. FASEB J, 14:1825–1836. 2000.
320.
ZalbaG, BeaumontFJ, San JoseG, FortunoA, FortunoMA, EtayoJC, DiezJ. Vascular NADH/NADPH oxidase is involved in enhanced superoxide production in spontaneously hypertensive rats. Hypertension, 35:1055–1061. 2000.
321.
ZalbaG, San JoséG, MorenoMU, FortuñoA, DíezJ. NADPH Oxidase-mediated oxidative stress: genetic studies of the p22phox gene in hypertension. Antioxid Redox Signal, 7:1327–1336. 2005.
322.
ZhanS, VazquezN, ZhanS, WientjesFB, BudarfML, SchrockE, RiedT, GreenED, ChanockSJ. Genomic structure, chromosomal localization, start of transcription, and tissue expression of the human p40-phox, a new component of the nicotinamide adenine dinucleotide phosphate-oxidase complex. Blood, 88:2714–2721. 1996.
323.
ZhangZ, YuJ, StantonRC. A method for determination of pyridine nucleotides using a single extract. Anal Biochem, 285:163–167. 2000.
